(5-chloro-1H-indol-2-yl)methanol, 97.0%, 5g

2-Acetyl-3-methylquinoxaline 1,4-dioxide, 95+%, 100g

4-Nitrobenzyl bromide, min 99%, for synthesis, 25 g, glass packaging

(4-(Cyclopropanesulfonamido)phenyl)boronic acid, 95.0%, 100mg

5-BROMO-1-METHYL-2-PHENYL-1H-IMIDAZOLE, 95%, 100mg

1-(7-Bromo-1H-indol-3-yl)ethanone, 95.0%, 5g

trans-4-Hydroxy-L-proline Methyl Ester Hydrochloride>98.0%(T)25g

4-[6-[[6-(1-Butoxyvinyl)-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl]amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester, 98%, 1g

3-(Cyclobutyl(4-methyl-4H-1,2,4-triazol-3-yl)methyl)aniline, 100mg

{[(4-methylphenyl)methyl]sulfanyl}methanimidamide hydrobromide, 95.0%, 2g

2-(Cyclohexylsulfanyl)benzene-1,4-diol, 250mg

3-(oxan-4-yl)propan-1-ol, 95.0%, 1g

Methyl 3-methylaminocrotonate, 97%, 25g